Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Disulfides × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 14 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colitis 2 Brenner Tumor 2 Brain Neoplasms 2 Adenocarcinoma, Mucinous 2 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡